Equivalent blood pressure reduction with angiotensin ii receptor antagonist based therapy compared with a calcium channel blocker in mild-to-moderate hypertensive patients of african origin

LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS

10.1097/01.hjh.0000501499.37300.e0 ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e548

Author(s):

Eun Joo Cho ◽

Hae Young Lee ◽

Ki Chul Sung ◽

Sungha Park ◽

Chang Gyu Park ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Blood Pressure Reduction ◽

Angiotensin Ii Receptor Blocker ◽

Pressure Reduction ◽

Angiotensin Ii Receptor ◽

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

Clinical and Experimental Nephrology ◽

10.1007/s10157-003-0241-3 ◽

2003 ◽

Vol 7 (3) ◽

pp. 221-230 ◽

Cited By ~ 13

Author(s):

Yasuhiko Iino ◽

Matsuhiko Hayashi ◽

Tetsuya Kawamura ◽

Tatsuo Shiigai ◽

Yasuhiko Tomino ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Renal Protection ◽

COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES: PP.17.160

10.1097/01.hjh.0000379086.40169.10 ◽

2010 ◽

Vol 28 ◽

pp. e297-e298

Author(s):

T Yokoi ◽

S Nakade ◽

H Masaki ◽

Y Komiyama ◽

M Masuda ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

MPS 15-08 BLOOD PRESSURE REDUCTION EFFICACY OF ANGIOTENSIN II RECEPTOR BLOCKER COMBINED WITH CALCIUM CHANNEL BLOCKER IS MORE SYNERGISTIC THAN WITH DIURETICS

10.1097/01.hjh.0000501072.66288.af ◽

2016 ◽

Vol 34 (Supplement 1) ◽

pp. e417

Author(s):

Eun Joo Cho ◽

Hae Young Lee ◽

Ki Chul Sung ◽

Sungha Park ◽

Chang Gyu Park ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Blood Pressure Reduction ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Pressure Reduction ◽

Angiotensin Ii Receptor

COMBINED EFFECTS OF CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN II RECEPTOR ANTAGONIST IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES

10.1097/00004872-201106001-00656 ◽

2011 ◽

Vol 29 ◽

pp. e236

Author(s):

T. Yokoi ◽

S. Nakade ◽

H. Masaki ◽

H. Takahashi

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

940 COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES-

10.1097/01.hjh.0000420851.56988.3d ◽

2012 ◽

Vol 30 ◽

pp. e271

Author(s):

Toyohiko Yokoi ◽

Junya Azuma ◽

Yukiyoshi Nakade ◽

Fumihiro Sanada ◽

Kazuma Iekushi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Combined Effects ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

PDB16 COST-EFFECTIVENESS OF BLOOD PRESSURE AND URINARY ALBUMIN CONTROL IN DIABETICS WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND A CALCIUM CHANNEL BLOCKER: PHARMACOECONOMIC ANALYSIS OF THE MARVAL TRIAL-THE CASE OF GERMANY

Value in Health ◽

10.1016/s1098-3015(10)61740-8 ◽

2003 ◽

Vol 6 (6) ◽

pp. 681

Author(s):

DG Smith ◽

A Gnanasakthy ◽

K Quednau

Keyword(s):

Blood Pressure ◽

Cost Effectiveness ◽

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Pharmacoeconomic Analysis ◽

Urinary Albumin ◽

Angiotensin Ii Receptor ◽

Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp39417 ◽

2009 ◽

Author(s):

K. Ohnishi ◽

M. Kohno ◽

K. Yukiiri ◽

H. Masugata ◽

Y. Wada ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Receptor Antagonist ◽

Channel Blocker ◽

Metabolic Effects ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Elderly Hypertensive ◽

Elderly Hypertensive Patients

506 COMPARISON OF THE EFFECT OF COMBINATION THERAPY WITH AN ANGIOTENSIN II RECEPTOR ANTAGONIST AND EITHER LOW-DOSE DIURETICS OR A CALCIUM CHANNEL BLOCKER ON CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH CARDIAC HYPERTROPHY

10.1097/01.hjh.0000420361.84667.a8 ◽

2012 ◽

Vol 30 ◽

pp. e149

Author(s):

Takafumi Okura ◽

Ken-ichi Miyoshi ◽

Jun Irita ◽

Masanori Johtoku ◽

Tomoaki Nagao ◽

...

Keyword(s):

Angiotensin Ii ◽

Combination Therapy ◽

Cardiac Hypertrophy ◽

Calcium Channel ◽

Receptor Antagonist ◽

Low Dose ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽

Angiotensin Ii Receptor Antagonist

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

Clinical and Experimental Hypertension ◽

10.3109/10641963.2010.503299 ◽

2011 ◽

Vol 33 (6) ◽

pp. 366-372 ◽

Cited By ~ 8

Author(s):

Toshihiko Ishimitsu ◽

Eri Ohno ◽

Nobuyuki Nakano ◽

Satoshi Furukata ◽

Akira Akashiba ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Angiotensin Ii ◽

Kidney Disease ◽

Calcium Channel ◽

Receptor Antagonist ◽

Calcium Channel Blocker ◽

Antihypertensive Therapy ◽

Channel Blocker ◽

Angiotensin Ii Receptor ◽